|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment losses – real estate, net of recoveries | |||||
| Loss on early extinguishment of debt | |||||
| Amortization of notes payable discount | |||||
| Amortization of debt costs | |||||
| Amortization of mortgages payable premium | |||||
| Amortization of interest rate hedges | |||||
| Settlement of forward starting swaps | |||||
| Gain on disposition of real estate | |||||
| Performance incentive plan expense | |||||
| Performance incentive plan payment | |||||
| Change in operating assets and liabilities, net of assets acquired and liabilities assumed: | |||||
| Decrease (increase) in receivables | |||||
| Increase in accrued rental income | |||||
| Decrease (increase) in other assets | |||||
| Increase (decrease) in accrued interest payable | |||||
| Increase (decrease) in other liabilities | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from the disposition of real estate | |||||
| Additions to real estate | |||||
| Principal payments received on mortgages and notes receivable | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from line of credit payable | |||||
| Repayment of line of credit payable | |||||
| Repayment of mortgages payable | |||||
| Proceeds from notes payable | |||||
| Repayment of notes payable | |||||
| Payment for early extinguishment of debt | |||||
| Payment of debt issuance costs | |||||
| Proceeds from issuance of common stock | |||||
| Stock issuance costs | |||||
| Redemption of Series F preferred stock | |||||
| Total redemption of Series F preferred stock | |||||
| Payment of Series F preferred stock dividends | |||||
| Total payment of Series F preferred stock dividends | |||||
| Payment of common stock dividends | |||||
| Noncontrolling interest distributions | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid, net of amount capitalized | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Change in other comprehensive income | |||||
| Right-of-use assets recorded in connection with lease liabilities | |||||
| Change in work in progress accrual | |||||
Loading...